ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

FDA Designates Zometa For Priority Review.

November 30, 2001

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999